Payment overview · 2025
General Payments
$14.70
1 reported records · 1 companies
Healthcare provider profile · identity verified
John Lidvall, MD
Allopathic & Osteopathic Physicians|Family Medicine · PEORIA, IL · NPI 1376856559
Verified facts
What the public records show
CMS Open Payments records show John Lidvall, MD received $14.70 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $14.70 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.70 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $14.70 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 745 | 191 |
| Atorvastatin Calcium | Atorvastatin Calcium | 647 | 181 |
| Lisinopril | Lisinopril | 533 | 143 |
| Amlodipine Besylate | Amlodipine Besylate | 410 | 111 |
| Simvastatin | Simvastatin | 404 | 104 |
| Omeprazole | Omeprazole | 383 | 95 |
| Montelukast Sodium | Montelukast Sodium | 305 | 91 |
| Gabapentin | Gabapentin | 295 | 92 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 84 |
| Metoprolol Succinate | Metoprolol Succinate | 261 | 74 |
| Hydrochlorothiazide | Hydrochlorothiazide | 256 | 71 |
| Eliquis | Apixaban | 255 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 251 | 66 |
| Losartan Potassium | Losartan Potassium | 249 | 75 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 229 | 59 |
| Furosemide | Furosemide | 224 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 218 | 66 |
| Metformin Hcl | Metformin Hcl | 207 | 63 |
| Prednisone | Prednisone | 197 | 119 |
| Lorazepam | Lorazepam | 188 | 51 |
| Metoprolol Tartrate | Metoprolol Tartrate | 179 | 40 |
| Famotidine | Famotidine | 160 | 36 |
| Donepezil Hcl | Donepezil Hcl | 155 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 152 | 41 |
| Alprazolam | Alprazolam | 149 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 147 | 41 |
| Tramadol Hcl | Tramadol Hcl | 144 | 47 |
| Allopurinol | Allopurinol | 139 | 26 |
| Trazodone Hcl | Trazodone Hcl | 139 | 42 |
| Sertraline Hcl | Sertraline Hcl | 138 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 130 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 129 | 30 |
| Metformin Hcl Er | Metformin Hcl | 127 | 39 |
| Xarelto | Rivaroxaban | 126 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 122 | 38 |
| Ozempic | Semaglutide | 117 | 27 |
| Memantine Hcl | Memantine Hcl | 113 | 25 |
| Glipizide Er | Glipizide | 112 | 30 |
| Meloxicam | Meloxicam | 111 | 40 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 111 | 13 |
| Potassium Chloride | Potassium Chloride | 105 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 101 | 46 |
| Tizanidine Hcl | Tizanidine Hcl | 99 | 42 |
| Atenolol | Atenolol | 98 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 97 | 33 |
| Warfarin Sodium | Warfarin Sodium | 97 | 26 |
| Ropinirole Hcl | Ropinirole Hcl | 90 | suppressed |
| Celecoxib | Celecoxib | 86 | 23 |
| Jardiance | Empagliflozin | 86 | 19 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 85 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 85 | 25 |
| Finasteride | Finasteride | 84 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 83 | 21 |
| Azithromycin | Azithromycin | 81 | 57 |
| Amoxicillin | Amoxicillin | 80 | 41 |
| Glimepiride | Glimepiride | 79 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 72 | 21 |
| Mounjaro | Tirzepatide | 72 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 68 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 67 | 19 |
| Pregabalin | Pregabalin | 67 | 20 |
| Carvedilol | Carvedilol | 66 | 24 |
| Buspirone Hcl | Buspirone Hcl | 65 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 63 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 60 | 18 |
| Propranolol Hcl | Propranolol Hcl | 55 | suppressed |
| Ezetimibe | Ezetimibe | 53 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 52 | 38 |
| Bupropion Xl | Bupropion Hcl | 51 | 18 |
| Clonazepam | Clonazepam | 50 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 50 | 30 |
| Benazepril Hcl | Benazepril Hcl | 49 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 49 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 38 |
| Ramipril | Ramipril | 47 | 12 |
| Topiramate | Topiramate | 47 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 46 | 43 |
| Alendronate Sodium | Alendronate Sodium | 45 | suppressed |
| Temazepam | Temazepam | 45 | suppressed |
| Nabumetone | Nabumetone | 44 | 16 |
| Sumatriptan Succinate | Sumatriptan Succinate | 44 | suppressed |
| Cephalexin | Cephalexin | 43 | 27 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 31 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 41 | 11 |
| Glipizide | Glipizide | 40 | suppressed |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 36 | suppressed |
| Diazepam | Diazepam | 36 | 16 |
| Liothyronine Sodium | Liothyronine Sodium | 35 | suppressed |
| Nifedipine Er | Nifedipine | 35 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 34 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 34 | suppressed |
| Estradiol | Estradiol | 33 | 11 |
| Lovastatin | Lovastatin | 33 | suppressed |
| Synthroid | Levothyroxine Sodium | 33 | suppressed |
| Rybelsus | Semaglutide | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 30 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 30 | suppressed |
| Tradjenta | Linagliptin | 30 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 29 | 29 |
| Trulicity | Dulaglutide | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Spironolactone | Spironolactone | 28 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 23 |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Repatha Syringe | Evolocumab | 27 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | 19 |
| Nystatin | Nystatin | 26 | 16 |
| Ondansetron Odt | Ondansetron | 26 | 13 |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 23 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Metronidazole | Metronidazole | 23 | 18 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 22 | suppressed |
| Telmisartan | Telmisartan | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Naproxen | Naproxen | 21 | 11 |
| Valacyclovir | Valacyclovir Hcl | 21 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | 11 |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Movantik | Naloxegol Oxalate | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 15 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 14 | 12 |
| Bumetanide | Bumetanide | 14 | suppressed |
| Ingrezza | Valbenazine Tosylate | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Desoximetasone | Desoximetasone | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Viberzi | Eluxadoline | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 11 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Klor-Con M10 | Potassium Chloride | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.70 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error